LIBELULA Trademark

Trademark Overview


On Wednesday, April 17, 2024, a trademark application was filed for LIBELULA with the United States Patent and Trademark Office. The USPTO has given the LIBELULA trademark a serial number of 79400586. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 4, 2025. This trademark is owned by Debiopharm International SA. The LIBELULA trademark is filed in the Pharmaceutical Products, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Publication of clinical trial results in the field of endocrinology

Pharmaceutical products focused on endocrinology, namely, medical preparations for the treatment of precocious puberty and for participants receiving gonadotropin releasing hormone agonist therapy for central precocious puberty

Providing medical and scientific research information in the field of pharmaceutical products; carrying out clinical trials for pharmaceutical products; scientific research for medical purposes in the field of endocrinology
libelula

General Information


Serial Number79400586
Word MarkLIBELULA
Filing DateWednesday, April 17, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 4, 2025

Trademark Statements


Goods and ServicesPublication of clinical trial results in the field of endocrinology
Goods and ServicesPharmaceutical products focused on endocrinology, namely, medical preparations for the treatment of precocious puberty and for participants receiving gonadotropin releasing hormone agonist therapy for central precocious puberty
Translation of Words in MarkThe wording "LIBELULA" has no meaning in a foreign language.
Goods and ServicesProviding medical and scientific research information in the field of pharmaceutical products; carrying out clinical trials for pharmaceutical products; scientific research for medical purposes in the field of endocrinology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 25, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateThursday, July 25, 2024
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 25, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDebiopharm International SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameDebiopharm International SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Thursday, July 25, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, July 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 29, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, October 30, 2024ASSIGNED TO EXAMINER
Wednesday, November 6, 2024NON-FINAL ACTION WRITTEN
Friday, November 8, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, November 14, 2024REFUSAL PROCESSED BY MPU
Thursday, November 14, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, November 30, 2024REFUSAL PROCESSED BY IB
Tuesday, December 31, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 31, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 31, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 9, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 4, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 29, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED